Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure
- PMID:23096426
- DOI: 10.1007/s00134-012-2708-8
Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure
Abstract
Purpose: The anesthetic-conserving device AnaConDa(®), a miniature vaporizer, allows volatile sedation in the intensive care unit (ICU). We investigated the effects of isoflurane sedation on cerebral and systemic physiology parameters in neuromonitored ICU stroke patients.
Methods: Included in the study were 19 consecutive ventilated patients with intracerebral hemorrhage (12), subarachnoid hemorrhage (4), and ischemic stroke (3) who were switched from intravenous propofol or midazolam to inhalative isoflurane sedation for an average of 3.5 days. During the sedation transition, the following parameters were assessed: mean arterial pressure (MAP), intracranial pressure (ICP), cerebral perfusion pressure (CPP), middle cerebral artery mean flow velocity (MFV) and cerebral fractional tissue oxygen extraction (FTOE), as well as systemic cardiopulmonary parameters and administered drugs.
Results: After the first hour, mean ICP showed an increase of 2.1 mmHg that was not clinically relevant. Likewise, MFV did not change. MAP and CPP, however, decreased by 6.5 and 6.3 mmHg, respectively. FTOE was reduced slightly from 0.24 to 0.21 (p = 0.03). Over an observation period of 12 h, ICP remained stable, while MAP and thus CPP showed distinct decreases (CPP: -10 mmHg at 6 h, p < 0.001; -7.5 mmHg at 12 h, p = 0.005, when compared to preswitch levels) despite a 1.5-fold increase in vasopressor administration.
Conclusions: We suggest that that it is possible to reach sufficient sedation levels in cerebrovascular ICU patients by applying volatile isoflurane long-term without a relevant increase in ICP, if baseline ICP values are low or only moderately elevated. However, caution should be exercised in view of isoflurane's decreasing effect on MAP and CPP. Multimodal neuromonitoring is strongly recommended when applying this off-label sedation method.
Similar articles
- Vesicoureteral Reflux.Lotfollahzadeh S, Leslie SW, Aeddula NR.Lotfollahzadeh S, et al.2024 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2024 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:33085409Free Books & Documents.
- Prescription of Controlled Substances: Benefits and Risks.Preuss CV, Kalava A, King KC.Preuss CV, et al.2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:30726003Free Books & Documents.
- Hyperbaric Physics.Jones MW, Brett K, Han N, Cooper JS, Wyatt HA.Jones MW, et al.2024 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2024 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:28846268Free Books & Documents.
- Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.Bedford J, Drikite L, Corbett M, Doidge J, Ferrando-Vivas P, Johnson A, Rajappan K, Mouncey P, Harrison D, Young D, Rowan K, Watkinson P.Bedford J, et al.Health Technol Assess. 2021 Nov;25(71):1-174. doi: 10.3310/hta25710.Health Technol Assess. 2021.PMID:34847987
- The 2023 Latin America report of theLancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.Hartinger SM, Palmeiro-Silva YK, Llerena-Cayo C, Blanco-Villafuerte L, Escobar LE, Diaz A, Sarmiento JH, Lescano AG, Melo O, Rojas-Rueda D, Takahashi B, Callaghan M, Chesini F, Dasgupta S, Posse CG, Gouveia N, Martins de Carvalho A, Miranda-Chacón Z, Mohajeri N, Pantoja C, Robinson EJZ, Salas MF, Santiago R, Sauma E, Santos-Vega M, Scamman D, Sergeeva M, Souza de Camargo T, Sorensen C, Umaña JD, Yglesias-González M, Walawender M, Buss D, Romanello M.Hartinger SM, et al.Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.Lancet Reg Health Am. 2024.PMID:38800647Free PMC article.Review.
Cited by
- Sedation options for the morbidly obese intensive care unit patient: a concise survey and an agenda for development.Aantaa R, Tonner P, Conti G, Longrois D, Mantz J, Mulier JP.Aantaa R, et al.Multidiscip Respir Med. 2015 Mar 7;10(1):8. doi: 10.1186/s40248-015-0007-2. eCollection 2015.Multidiscip Respir Med. 2015.PMID:25883785Free PMC article.
- Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review.Herzog-Niescery J, Seipp HM, Weber TP, Bellgardt M.Herzog-Niescery J, et al.J Clin Monit Comput. 2018 Aug;32(4):667-675. doi: 10.1007/s10877-017-0055-6. Epub 2017 Aug 31.J Clin Monit Comput. 2018.PMID:28861655Review.
- A technical review of the history, development and performance of the anaesthetic conserving device "AnaConDa" for delivering volatile anaesthetic in intensive and post-operative critical care.Farrell R, Oomen G, Carey P.Farrell R, et al.J Clin Monit Comput. 2018 Aug;32(4):595-604. doi: 10.1007/s10877-017-0097-9. Epub 2018 Jan 31.J Clin Monit Comput. 2018.PMID:29388094Free PMC article.Review.
- Volatile Isoflurane in Critically Ill Coronavirus Disease 2019 Patients-A Case Series and Systematic Review.Flinspach AN, Zacharowski K, Ioanna D, Adam EH.Flinspach AN, et al.Crit Care Explor. 2020 Oct 21;2(10):e0256. doi: 10.1097/CCE.0000000000000256. eCollection 2020 Oct.Crit Care Explor. 2020.PMID:33134946Free PMC article.
- Isoflurane Sedation in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation Treatment for Cardiogenic Shock-An Observational Propensity-Matched Study.Scherer C, Kupka D, Stocker TJ, Joskowiak D, Scheuplein H, Schönegger CM, Born F, Stremmel C, Lüsebrink E, Stark K, Orban M, Petzold T, Peterss S, Hausleiter J, Hagl C, Massberg S, Orban M.Scherer C, et al.Crit Care Explor. 2020 Mar 24;2(3):e0086. doi: 10.1097/CCE.0000000000000086. eCollection 2020 Mar.Crit Care Explor. 2020.PMID:32259109Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical